RECORD // Company

Dare Bioscience, Inc.

Formerly: Cerulean Pharma Inc.; Tempo Pharmaceuticals Inc

Built 2026-11-22T00:39:44Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (1 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

SEC EDGAR (1)
Records under a former name (1)

The name on these records was this company's name in the past (SEC name history). An old name can also belong to an unrelated organization, so they are shown apart and are not counted above.

Matched by name only, not merged (2)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • DARE BIOSCIENCE INC · Ca business · same registered legal name as 'Dare Bioscience, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • DARE BIOSCIENCE, INC. · USAspending · same registered legal name as 'Dare Bioscience, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare

4 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-16 · accession 0001401914-26-000055

ItemValuePeriodFormFiledAccessionReport
Revenue$47,6283 months ended 2026-09-3010-Q2026-11-160001401914-26-0000552026-11-22 00:39 UTCReport an error
Net income (loss)$-3,157,9363 months ended 2026-09-3010-Q2026-11-160001401914-26-0000552026-11-22 00:39 UTCReport an error
Cash and cash equivalents$11,531,684at 2026-09-3010-Q2026-11-160001401914-26-0000552026-11-22 00:39 UTCReport an error
Contract liabilities, noncurrent (from an earlier report)$0at 2025-12-3110-K2026-03-260001401914-26-0000042026-11-22 00:39 UTCReport an error

Negative as reported in the filing.

Not in this report's XBRL: Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001401914
Ticker
DARE
EIN
204139823
CUSIP
23666P200
Record ID
sx:sec:0001401914

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

31 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-20SEC EDGAR company profile2026-11-22 00:39 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2026-11-20SEC EDGAR company profile2026-11-22 00:39 UTCReport an error
State of incorporationDE2026-11-20SEC EDGAR company profile2026-11-22 00:39 UTCReport an error
Fiscal year end (MMDD)12312026-11-20SEC EDGAR company profile2026-11-22 00:39 UTCReport an error
Business address3655 NOBEL DRIVE, SUITE 260, SAN DIEGO, CA, 921222026-11-20SEC EDGAR company profile2026-11-22 00:39 UTCReport an error
ExchangesNasdaq2026-11-20SEC EDGAR company profile2026-11-22 00:39 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$1,030,1932025-12-3110-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax2026-11-22 00:39 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-13,399,2742025-12-3110-K, XBRL NetIncomeLoss2026-11-22 00:39 UTCReport an error
Total assets (at 2025-12-31)$32,474,5632025-12-3110-K, XBRL Assets2026-11-22 00:39 UTCReport an error
Stockholders' equity (at 2025-12-31)$2,842,6342025-12-3110-K, XBRL StockholdersEquity2026-11-22 00:39 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$24,711,3562025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 00:39 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$-9,885,8702025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 00:39 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$385,2782025-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-22 00:39 UTCReport an error
Operating lease liabilities (at 2025-12-31)$1,161,9172025-12-3110-K, XBRL OperatingLeaseLiability2026-11-22 00:39 UTCReport an error
Form D total offering amount (D filed 2026-08-20)$12,375,0542026-08-20D2026-11-22 00:39 UTCReport an error
Form D total amount sold (D filed 2026-08-20)$12,375,0542026-08-20D2026-11-22 00:39 UTCReport an error
Form D industry groupBiotechnology2026-08-20D2026-11-22 00:39 UTCReport an error
Form D revenue rangeDecline to Disclose2026-08-20D2026-11-22 00:39 UTCReport an error
Form D date of first sale2026-08-172026-08-20D2026-11-22 00:39 UTCReport an error
8-K Item 3.01, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (filed 2026-10-02)On September 28, 2026, Daré Bioscience, Inc. (“Daré”) received a letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying Daré that, for the last 30 consecutive business days, the closing bid price for Daré’s common stock was below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The letter has no immediate effect on the listing of Daré’s common stock on the Nasdaq Capital Market. In accordance with Nasdaq listing rules, Daré has been provided an initial period of 180 calendar days, or until March 29, 2027 (the…2026-10-02SEC EDGAR 8-K 0001401914-26-000052 (text as filed, excerpt)2026-11-22 00:39 UTCReport an error
Plan (pension, plan no. 001)DARE BIOSCIENCE, INC. 401(K) PROFIT SHARING PLAN TRUST: 45 participants2025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-22 00:39 UTCReport an error
Largest institutional holder #1 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$1,352,2502026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:39 UTCReport an error
Largest institutional holder #2 (13F as filed): GEODE CAPITAL MANAGEMENT, LLC$295,6422026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:39 UTCReport an error
Largest institutional holder #3 (13F as filed): US BANCORP \DE\$255,1412026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:39 UTCReport an error
Largest institutional holder #4 (13F as filed): VANGUARD FIDUCIARY TRUST CO$192,5782026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:39 UTCReport an error
Largest institutional holder #5 (13F as filed): BlackRock, Inc.$135,5642026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:39 UTCReport an error
Largest institutional holder #6 (13F as filed): STATE STREET CORP$100,0462026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:39 UTCReport an error
Largest institutional holder #7 (13F as filed): JANE STREET GROUP, LLC$76,1542026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:39 UTCReport an error
Largest institutional holder #8 (13F as filed): NORTHERN TRUST CORP$72,1812026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:39 UTCReport an error
Largest institutional holder #9 (13F as filed): LPL Financial LLC$31,4162026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:39 UTCReport an error
Largest institutional holder #10 (13F as filed): RAYMOND JAMES FINANCIAL INC$31,3632026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:39 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.